[Efficacy and patient benefit of treatment of irritated skin with ointments containing dexpanthenol: health services research (observational study) on self-medication in a pharmaceutical network]
- PMID: 19384536
- DOI: 10.1007/s00105-009-1729-x
[Efficacy and patient benefit of treatment of irritated skin with ointments containing dexpanthenol: health services research (observational study) on self-medication in a pharmaceutical network]
Abstract
Background: Products containing dexpanthenol are used to treat irritated and inflamed skin. So far there is a lack of data for the evidence of patient-relevant benefits.
Objective: Assessment of the patient-relevant benefit of ointments containing dexpanthenol in the self-medicated therapy of irritated skin.
Methods: Prospective, observational study in a network of 392 pharmacies. Consecutive recruitment of n=1,886 patients with symptoms of irritated skin, including non-inflammatory intervals of atopic eczema, other xerotic skin conditions and impairment of skin barrier. The patient-relevant benefit was ascertained prior to and 7-10 days after treatment through the patient-benefit index (PBI).
Results: The PBI showed that 91.5% of the patients experienced a relevant benefit from treatment. 94.7% directly indicated to have had achieved successful therapeutic results. All symptoms of irritated skin (e.g. xerosis, erythema, desquamation) significantly improved (p<or=0,001). The subjective response was independent of age, gender and underlying skin disease.
Conclusion: High patient-relevant benefits were observed in the treatment of irritated skin with dexpanthenol ointment.
Similar articles
-
Hamamelis in children with skin disorders and skin injuries: results of an observational study.Eur J Pediatr. 2007 Sep;166(9):943-8. doi: 10.1007/s00431-006-0363-1. Epub 2006 Dec 20. Eur J Pediatr. 2007. PMID: 17177071 Clinical Trial.
-
Comparative trial of 5% dexpanthenol in water-in-oil formulation with 1% hydrocortisone ointment in the treatment of childhood atopic dermatitis: a pilot study.J Drugs Dermatol. 2012 Mar;11(3):366-74. J Drugs Dermatol. 2012. PMID: 22395588 Clinical Trial.
-
Molecular effects of photon irradiation and subsequent aftercare treatment with dexpanthenol-containing ointment or liquid in 3D models of human skin and non-keratinized oral mucosa.Exp Dermatol. 2021 May;30(5):745-750. doi: 10.1111/exd.14266. Epub 2021 Jan 5. Exp Dermatol. 2021. PMID: 33403711
-
Topical use of dexpanthenol: a 70th anniversary article.J Dermatolog Treat. 2017 Dec;28(8):766-773. doi: 10.1080/09546634.2017.1325310. Epub 2017 May 14. J Dermatolog Treat. 2017. PMID: 28503966 Review.
-
Topical use of dexpanthenol in skin disorders.Am J Clin Dermatol. 2002;3(6):427-33. doi: 10.2165/00128071-200203060-00005. Am J Clin Dermatol. 2002. PMID: 12113650 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources